Ligands for targeting of S1P receptors for in vivo imaging and treatment of diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9345791
APP PUB NO 20140170067A1
SERIAL NO

14237572

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel compounds of formulae (I) and (II) which are useful in the prevention, treatment and diagnosis, in vivo diagnosis of diseases or disorders related to S1P receptors, in particular, in diseases which are connected to the regulatory function of sphingosine-1-phosphate (S1P) and its analogs, such as inflammation, pain, autoimmune diseases and cardiovascular diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTERSCHLOSSPLATZ 2 MUENSTER 48149

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Haufe, Guenter Muenster, DE 3 2
Keul, Petra Duesseldorf, DE 1 0
Levkau, Bodo Muenster, DE 4 9
Schaefers, Michael Muenster, DE 4 2
Schilson, Stefani Silke Muenster, DE 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 24, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00